Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
2.860
+0.070 (2.51%)
At close: Apr 18, 2024, 4:00 PM
2.810
-0.050 (-1.75%)
After-hours: Apr 18, 2024, 5:20 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $377.41 million as of April 18, 2024. Its market cap has increased by 30.19% in one year.
Market Cap
377.41M
Enterprise Value
392.43M
1-Year Change
30.19%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $377.41M, an increase of 0.22%. That is a compound annual growth rate of 0.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 368.20M | -2.44% |
Apr 16, 2024 | 377.40M | 3.62% |
Apr 15, 2024 | 364.20M | -4.18% |
Apr 12, 2024 | 380.10M | -3.99% |
Apr 11, 2024 | 395.90M | 1.70% |
Apr 10, 2024 | 389.30M | 1.04% |
Apr 9, 2024 | 385.30M | -1.68% |
Apr 8, 2024 | 391.90M | 4.93% |
Apr 5, 2024 | 373.50M | 1.08% |
Apr 4, 2024 | 369.50M | 1.09% |
Apr 3, 2024 | 365.50M | 6.13% |
Apr 2, 2024 | 344.40M | -6.79% |
Apr 1, 2024 | 369.50M | -1.41% |
Mar 28, 2024 | 374.80M | 2.91% |
Mar 27, 2024 | 364.20M | 5.35% |
Mar 26, 2024 | 345.70M | - |
Mar 25, 2024 | 345.70M | 0.38% |
Mar 22, 2024 | 344.40M | -1.88% |
Mar 21, 2024 | 351.00M | -5.01% |
Mar 20, 2024 | 369.50M | 1.82% |
Mar 19, 2024 | 362.90M | - |
Mar 18, 2024 | 362.90M | -3.51% |
Mar 15, 2024 | 376.10M | 0.35% |
Mar 14, 2024 | 374.80M | -5.33% |
Mar 13, 2024 | 395.90M | 2.04% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Amarin Corporation | 374.93M |
Mereo BioPharma Group | 373.14M |
PepGen | 372.08M |
Humacyte | 371.54M |
Ocugen | 369.36M |
Alto Neuroscience | 362.40M |
Jasper Therapeutics | 358.82M |
Adaptive Biotechnologies | 354.02M |